CLSI M07 11th Edition

Methods For Dilution Antimicrobial Susceptibility Tests For Bacteria That Grow Aerobically

M07 11th Edition

Standard Organization: CLSI

CLSI M07 11th Edition
Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically

Recognition NumberInVitro Diagnostics
Recognition Date2018-09-17
Recognition List050
Recognition Number7-279
Extent Complete standard
Standards Orgs CLSI Clinical Laboratory Standards Institute https://clsi.org/
STG InVitro Diagnostics
FDA Tech  Ribhi Shawar   FDA/OMPT/CDRH/OIR/DMD/BAC1/   301-796-6698   ribhi.shawar@fda.hhs.gov

Rationale:

This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies.

Scope:

This standard describes standard broth (macrodiluation and microdiluation) and agar diluation emthods for determining in vitro susceptibility to antimicrobial agents for bacteria that grow aerobically.

Code of Federal Regulations:

Regulation Number Device Name Device Class Product Code
§866.1645 System, Test, Automated, Antimicrobial Susceptibility, Short Incubation Class 2 LON
§866.1640 Instrument For Auto Reader & Interpretation Of Overnight Suscept. Systems Class 2 LRG
§866.1640 Manual Antimicrobial Susceptibility Test Systems Class 2 JWY
§866.1640 Panels, Test, Susceptibility, Antimicrobial Class 2 LTT
§866.1640 Susceptibility Test Cards, Antimicrobial Class 2 LTW

FDA Guidance:

Class II Special Controls Guidance Document: Antimicrobial Susceptibility Test (AST) Systems, Issued March 5, 2007.


© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.